publication date: Dec. 1, 2010

In this issue: 

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies.

Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall.

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer.

ASCO Begins Practice Certification Program.

Download (PDF 1.1MB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.